Compare GSK plc (GSK) vs Invesco Preferred ETF (PGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Invesco Preferred ETF — how do they compare? GSK plc trades at $50.34 (market cap $101.13B), while Invesco Preferred ETF trades at $10.67. The key difference: GSK plc pays a 3.61% dividend while Invesco Preferred ETF pays none, and GSK plc is trading nearer its 52-week high, Invesco Preferred ETF nearer its low. Which is the better fit depends on your goals.
| GSK | PGX | |
|---|---|---|
Market Cap | $101.13B | — |
Sector | Health | — |
52-Week High | $61.18 | $11.87 |
52-Week Low | $38.96 | $10.65 |
Enterprise Value | $121.57B | — |
Dividend Yield | 3.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.
The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.
PGX trades at $10.67, up 0.19% today, with a technical outlook leaning bearish based on moving averages. The stock shows neutral momentum oscillators. Recent corporate actions include declared dividends for 2026. Key financial ratios such as P/E and ROE are not available in the provided data, limiting fundamental assessment.
The outlook is cautious due to the bearish technical signals and lack of current fundamental data. Investment opportunity hinges on future financial disclosures and business performance. Risks include market volatility and potential operational challenges, requiring close monitoring of upcoming earnings reports and analyst updates.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Invesco Preferred ETF
The fund generally will invest at least 80% of its total assets in the components of the index. Strictly in accordance with its guidelines and mandated procedures, ICE Data Indices, LLC selects securities for the index, which is a market capitalization-weighted index designed to measure the performance of the fixed rate US dollar-denominated preferred securities market.
Read more on PGX →
